Filter by Brand
Filter by Topic
Introducing Latitude Reporting -- a faster, easier way to find the patients you care about
Latitude Reporting enables you to use billions of commercial claims to rapidly build patient cohorts that target specific disease states in real-time...
3 pain points life sciences companies face gaining insights on their patient populations
Explore the 3 pain points life sciences companies face with leverage data to gain insights into their ideal patient populations.
3 ways telehealth can help provider organizations improve operational performance
When most people think of telehealth services, they're probably thinking of a patient communicating directly with a care provider. However, providers...
Target physicians precisely with claims-based specialty data
We’re excited to announce the launch of a brand-new feature within our PhysicianView product: Claims-based specialty designations.
The exciting future of telehealth in a hybrid health world
Using healthcare commercial intelligence from our database, let’s explore the use of telehealth in two specialties and the broader role it plays in...
Definitive Healthcare goes public
This morning, Definitive Healthcare had the amazing opportunity to ring the opening bell of Nasdaq to celebrate the initial public offering of our...
4 tips for planning your 2022 life sciences marketing strategy
As we approach the end of the year, that also means it's time for most biopharmaceutical and medical device companies to start planning next year's...
Overcoming the 510(k) hurdle and getting your product to market
While the FDA submission process can be long and challenging, getting your product into the hands of customers presents its own hurdles. Fortunately...
What does the end of emergency use authorizations mean for healthcare providers?
In recent months, the Food and Drug Administration has been winding down its issuance of emergency use authorizations (EUAs). This poses a significant...
Personalizing cancer care with precision medicine
It’s a situation all too common for many. After going in for a routine screening, the doctor notices an abnormality. After the biopsy, you get the...
